Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > What is a Registration Rights Agreement?
View:
Post by RetailRube on Sep 22, 2015 3:22pm

What is a Registration Rights Agreement?

In Sedar.com "Other Material Contracts" filed on Aug 19, 2015 there are two documents for each of the new US investors.  One document applies to the US and one to Canada.  The document is called a Registration Rights Agreement.  Based on reading the document as well as Wikipedia, I think it says the new shareholder can compel TST to issue a prospectus if the shareholder wants to sell their shares.  Apparently, the new shareholders need a prosectus because they are deemed to be a controlling shareholder, although with only 20% ownership, that's something I've never seen before.  The agreement also allows these shareholders to participate (sell some of their holding) in any TST share placement done by public placement.  So if it's that hard for them to exit their position, it doesn't sound like they will be dumping shares as soon as the lockup period expires on Dec 20, 2016.  So no more artificial selling pressure in the near-term like we are currently experiencing with the 21m warrant/option expiry.

However, will our new major US shareholder with 20% shareholding request a seat on the Board of Directors?  Wells put Gubbitz on the Board when he only controlled 6% of the shares.  We will find out when we get our AGM proxy voting document in October with all the resolutions and candidates for BOD.
Comment by RetailRube on Sep 22, 2015 3:24pm
Correction:  Lockup period ends Dec 20, 2015, not 2016.  I always make one mistake per post, even with multiple proof-reads. (sigh)
Comment by conspiTheory on Sep 22, 2015 7:29pm
when will the adcomm be? if you check https://www.fdatracker.com/fda-calendar/ you will see the time interval between adcomm and pdufa of some other companies. it seems like 1 month. Now the adcomm might add some delay (just for rgb)... https://www.ncbi.nlm.nih.gov/pubmed/2592579 but do we care at that point, delay mean accepted anyway. So January 2016 with all the shares available for trading.  ...more  
Comment by cheetio on Sep 23, 2015 6:26am
Comment by cheetio on Sep 23, 2015 6:30am
....No fairy's in that article....hey...When investors bid up the stocks of companies with phase III drugs, the companies raise money, which leads to bigger paychecks, more stock and options for company executives. It's a self-serving feedback loop.
Comment by cheetio on Sep 23, 2015 6:49am
No fairy......The market also incentivizes larger companies to be more disciplined with R&D expenses. Wasted R&D steals from earnings...........
Comment by HighteawithIntrepid on Sep 23, 2015 9:28am
If one accepts our phase 3 trial was conducted  by ENDO and their current market cap exceeds 15 billion our chances are 60% not zero. So we don't fall under the spell of the F-R rule of under $300 million. Although not huge I expect some news to come out of the New York D&P show by the 30th. Remember this is supposed to be a 1/20  position (or smaller) not a winner take all coin ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities